IVISIONWORKS CO.,LTD. Logo

IVISIONWORKS CO.,LTD.

Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.

469750 | KO

Overview

Corporate Details

ISIN(s):
KR7469750004
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학21로 54 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IVISIONWORKS CO., LTD. operates with a dual focus on social impact investment and digital healthcare. Through its accelerator arm, Visionworks Ventures, the company discovers, nurtures, and invests in early-stage impact startups and social ventures aligned with the UN Sustainable Development Goals (SDGs). It provides comprehensive support programs, including mentorship, business development education, and access to seed investment and global acceleration opportunities. Concurrently, its Visionworks Neurons division develops digital therapeutics, focusing on neuroplasticity-based cognitive rehabilitation solutions for conditions such as Mild Cognitive Impairment (MCI) and emotional-cognitive digital treatments for Autism Spectrum Disorder (ASD).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-09-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 925.7 KB
2025-07-01 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.8 KB
2025-06-27 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Korean 12.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 996.8 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.3 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 80.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.9 KB
2025-03-07 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.2 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.0 KB
2025-02-20 00:00
Regulatory News Service
본점소재지변경
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all IVISIONWORKS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVISIONWORKS CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVISIONWORKS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.